News
Company news and developments, with original sources and dates.
Updated from source
Funding RSS ↗Zhiran Medical Raises RMB 600M in Equity Investment
On September 22, 2026, Beijing-based Zhiran Medical, a next-generation flexible brain-computer interface platform developer, raised RMB 600 million from over ten investors including Shunxi Fund, Sequoia China, Junlian Capital, Shunwei Capital, Meituan Longzhu and CAS Star. It was founded by Dr. Song Qi.
Horizon Robotics subsidiary D-Robotics raises USD 400 million Series C
On 2026/9/17, D-Robotics, a robotics subsidiary of Horizon Robotics, announced USD 400 million in Series C funding led by Mirae Asset. Follow-on investors included Meituan’s strategic investment arm, government-backed platforms including Hefei Guotou and Nanshan Zhanxintou, and leading institutions including Cathay Capital, GF Xinde and GL Ventures. Since its Series A in 2025, D-Robotics had disclosed USD 770 million in cumulative funding.
Xinuoweilai Xynova raises RMB 500 million in Series A+ financing
On 2026-07-17, according to Xiniu Data, Xinuoweilai Xynova completed Series A+ financing, raising RMB 500 million. Investors were lead investor Meituan, participating investor Weilai Capital, participating investor Zhaoshangju Capital, participating investor Xiaomi Technology, participating investor Zhewenhulian Group Co., Ltd., participating investor Qingdao Xinjianweilaiguquan Investment Partnership (Limited Partnership), other participating investors. The company is a supplier of core components for humanoid robots.
Deemos raises hundreds of millions of CNY in new round led by Cathay Capital and Shanghai State-owned Capital Investment’s Xiandao fund
On 2026/6/25, 36Kr reported that Deemos had raised hundreds of millions of CNY in new funding led by Cathay Capital and Shanghai State-owned Capital Investment’s Xiandao fund, with existing investors ByteDance, Meituan Long-Z, HongShan and BlueRun Ventures participating again.
Mindverse raises USD 50 million in Series A financing
On 2026-06-02, according to Xiniu Data, Mindverse completed Series A financing, raising USD 50 million. Investors were lead investor Meituan, participating investor Yuanhepuhua, participating investor Shaoyin Technology, participating investor Bianliang Capital, participating investor Mayi Group, participating investor Yuanyi Capital, participating investor Xianxing Capital, participating investor Hongshan China, participating investor Zhenge, participating investor Gaorong, other participating investors. The company is a developer of personalized individual models.
Meituan reports CNY 91.039 billion first-quarter revenue, advances AI agent services
On 2026/6/1, IT Home reported that China’s Meituan had generated CNY 91.039 billion first-quarter revenue, approximately USD 13.482 billion, with a CNY 6.827 billion net loss. It disclosed that AI agent Xiaomei would collaborate with Tencent’s Yuanbao.
Tianji Intelligence raises RMB 1 billion in Series B financing
On 2026-05-25, according to Xiniu Data, Tianji Intelligence completed Series B financing, raising RMB 1 billion. Investors were co-lead investor Gaoling Venture Capital, co-lead investor Meituan, Tengxun, Gaorong Venture Capital and others. The company is a developer of embodied AI robots.
Zibianliang Robotics raises hundreds of millions of RMB in equity financing
On 2026-02-25, according to Xiniu Data, Zibianliang Robotics completed equity financing, raising hundreds of millions of RMB. Investors were Guangfaxinde, Qifu Capital, Hongshan China, Meituanlongzhu and others.
Galaxea raises CNY1 billion in Series B financing
On 2026/1/30, according to Xiniu Data, Galaxea raised CNY1 billion in Series B financing. Investors included Zhengxingu Capital, Meituan Longzhu, Hillhouse Venture Capital, Xianghe Capital, and others.
Deemos raises tens of millions of US dollars in Series A funding led by Meituan Longzhu and ByteDance
On 2025/1/13, The Beijing News reported that Deemos raised tens of millions of US dollars in Series A funding, led by Meituan Longzhu and ByteDance, with participation from Hongshan China Seed Fund and MiraclePlus.